rs34030799

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_001368809.2(AMPD2):​c.1104G>A​(p.Ser368Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0227 in 1,613,870 control chromosomes in the GnomAD database, including 602 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.016 ( 41 hom., cov: 32)
Exomes 𝑓: 0.023 ( 561 hom. )

Consequence

AMPD2
NM_001368809.2 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -3.70

Publications

5 publications found
Variant links:
Genes affected
AMPD2 (HGNC:469): (adenosine monophosphate deaminase 2) The protein encoded by this gene is important in purine metabolism by converting AMP to IMP. The encoded protein, which acts as a homotetramer, is one of three AMP deaminases found in mammals. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
AMPD2 Gene-Disease associations (from GenCC):
  • pontocerebellar hypoplasia type 9
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics
  • hereditary spastic paraplegia 63
    Inheritance: Unknown, AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.047).
BP6
Variant 1-109628106-G-A is Benign according to our data. Variant chr1-109628106-G-A is described in ClinVar as [Benign]. Clinvar id is 474994.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-3.7 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0524 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMPD2NM_001368809.2 linkc.1104G>A p.Ser368Ser synonymous_variant Exon 11 of 19 ENST00000528667.7 NP_001355738.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMPD2ENST00000528667.7 linkc.1104G>A p.Ser368Ser synonymous_variant Exon 11 of 19 1 NM_001368809.2 ENSP00000436541.2

Frequencies

GnomAD3 genomes
AF:
0.0162
AC:
2472
AN:
152204
Hom.:
41
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00603
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.00942
Gnomad ASJ
AF:
0.0239
Gnomad EAS
AF:
0.000770
Gnomad SAS
AF:
0.0588
Gnomad FIN
AF:
0.00735
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0233
Gnomad OTH
AF:
0.0134
GnomAD2 exomes
AF:
0.0199
AC:
5002
AN:
251042
AF XY:
0.0222
show subpopulations
Gnomad AFR exome
AF:
0.00646
Gnomad AMR exome
AF:
0.00665
Gnomad ASJ exome
AF:
0.0254
Gnomad EAS exome
AF:
0.000272
Gnomad FIN exome
AF:
0.00828
Gnomad NFE exome
AF:
0.0226
Gnomad OTH exome
AF:
0.0165
GnomAD4 exome
AF:
0.0234
AC:
34146
AN:
1461548
Hom.:
561
Cov.:
34
AF XY:
0.0241
AC XY:
17544
AN XY:
727082
show subpopulations
African (AFR)
AF:
0.00496
AC:
166
AN:
33478
American (AMR)
AF:
0.00689
AC:
308
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0251
AC:
655
AN:
26126
East Asian (EAS)
AF:
0.000126
AC:
5
AN:
39698
South Asian (SAS)
AF:
0.0514
AC:
4431
AN:
86238
European-Finnish (FIN)
AF:
0.00836
AC:
445
AN:
53250
Middle Eastern (MID)
AF:
0.0237
AC:
136
AN:
5748
European-Non Finnish (NFE)
AF:
0.0240
AC:
26647
AN:
1111906
Other (OTH)
AF:
0.0224
AC:
1353
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
1944
3888
5831
7775
9719
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1000
2000
3000
4000
5000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0162
AC:
2469
AN:
152322
Hom.:
41
Cov.:
32
AF XY:
0.0160
AC XY:
1194
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00601
AC:
250
AN:
41566
American (AMR)
AF:
0.00941
AC:
144
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.0239
AC:
83
AN:
3472
East Asian (EAS)
AF:
0.000965
AC:
5
AN:
5184
South Asian (SAS)
AF:
0.0580
AC:
280
AN:
4828
European-Finnish (FIN)
AF:
0.00735
AC:
78
AN:
10614
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0233
AC:
1583
AN:
68034
Other (OTH)
AF:
0.0132
AC:
28
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
125
250
375
500
625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0179
Hom.:
21
Bravo
AF:
0.0148
Asia WGS
AF:
0.0210
AC:
73
AN:
3478
EpiCase
AF:
0.0243
EpiControl
AF:
0.0233

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Aug 25, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Hereditary spastic paraplegia 63 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary spastic paraplegia 63;C4014354:Pontocerebellar hypoplasia type 9 Benign:1
Feb 01, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pontocerebellar hypoplasia type 9 Benign:1
Apr 11, 2023
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.70
CADD
Benign
2.1
DANN
Benign
0.84
PhyloP100
-3.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34030799; hg19: chr1-110170728; API